Literature DB >> 11519714

A comparison of patient reading performance and preference: optical devices, handheld CCTV (Innoventions Magni-Cam), or stand-mounted CCTV (Optelec Clearview or TSI Genie).

G L Goodrich1, J Kirby.   

Abstract

BACKGROUND: Clinicians frequently prescribe reading devices for low vision patients having a central field loss. This study seeks to provide comparative information the clinician can use to assist patients in selecting the most cost-effective device(s) for reading.
METHOD: In this study we compared optical devices with two types of closed-circuit televisions (CCTVs) that differed in two important characteristics: price, and whether the camera was stand-mounted with an X-Y table or whether the camera was handheld. A "within-subjects" design was used with 22 subjects. The primary comparisons between devices were subject reading speed, duration, and preference.
RESULTS: Subject reading speed and duration were significantly greater with the CCTV systems than with optical devices; however, no significant performance differences were found between the two types of CCTVs. Patients did express a clear preference for one versus the other type of CCTV, with an overall preference for the stand-mounted system. When asked to consider the price differential between types of CCTVs, patient preferences were about equally divided.
CONCLUSIONS: Clinicians can expect significantly better initial reading performance for patients with central visual-field losses when reading with CCTVs versus optical devices. Handheld CCTVs, when compared with stand-mounted systems, are less expensive, provide equal performance, and have slightly lower subject preference ratings. The current study provides clinicians with objective performance data and subjective preference data that can be used to help patients with central visual-field losses select the most cost-effective reading device.

Entities:  

Mesh:

Year:  2001        PMID: 11519714

Source DB:  PubMed          Journal:  Optometry        ISSN: 1558-1527


  9 in total

Review 1.  Tablet and Smartphone Accessibility Features in the Low Vision Rehabilitation.

Authors:  Danielle Irvine; Alex Zemke; Gregg Pusateri; Leah Gerlach; Rob Chun; Walter M Jay
Journal:  Neuroophthalmology       Date:  2014-03-11

Review 2.  [Closed-circuit television systems : Current importance and tips on adaptation and prescription].

Authors:  K Rohrschneider; Y Bayer; B Brill
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

3.  [The IOL-Vip system : Principles and clinical application].

Authors:  R Khoramnia; C W von Mohrenfels; J P Salgado; B Schweiger; M Engel; J Hadeler; C P Lohmann
Journal:  Ophthalmologe       Date:  2010-03       Impact factor: 1.059

Review 4.  Reading aids for adults with low vision.

Authors:  Gianni Virgili; Ruthy Acosta; Lori L Grover; Sharon A Bentley; Giovanni Giacomelli
Journal:  Cochrane Database Syst Rev       Date:  2013-10-23

Review 5.  The burden of age-related macular degeneration.

Authors:  Jordana K Schmier; Mechelle L Jones; Michael T Halpern
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

6.  Effects of standard training in the use of closed-circuit televisions in visually impaired adults: design of a training protocol and a randomized controlled trial.

Authors:  Marloes C Burggraaff; Ruth M A van Nispen; Bart J M Melis-Dankers; Ger H M B van Rens
Journal:  BMC Health Serv Res       Date:  2010-03-10       Impact factor: 2.655

Review 7.  Reading aids for adults with low vision.

Authors:  Gianni Virgili; Ruthy Acosta; Sharon A Bentley; Giovanni Giacomelli; Claire Allcock; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2018-04-17

8.  Evaluation of a gaze-controlled vision enhancement system for reading in visually impaired people.

Authors:  Carlos Aguilar; Eric Castet
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

9.  Visual rehabilitation of patients with corneal diseases.

Authors:  Michael Oeverhaus; Dirk Dekowski; Herbert Hirche; Joachim Esser; Barbara Schaperdoth-Gerlings; Anja Eckstein
Journal:  BMC Ophthalmol       Date:  2020-05-06       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.